文献速递临床试验与 GCP

剥脱-溶解-修复护肤法治疗毛周角化病的疗效与安全性:随机对照临床试验研究方案

Efficacy and safety of the Exfoliate-Dissolve-Repair skin care approach in the treatment of keratosis pilaris: a randomized controlled clinical trial study protocol.
PubMed 文献 · Trials · 2026-02-24

本研究为单中心随机对照试验,纳入18-35岁毛周角化病患者72例,随机分为剥脱-溶解-修复(EDR)综合护肤干预组与0.1%维A酸乳膏对照组。试验包括4周治疗期,于治疗开始后第7、14、21、28天进行指标检测和数据收集,主要结局为毛囊丘疹改善指数和皮肤角化程度评估,次要结局包括皮肤含水量、经皮水分丢失、皮肤弹性等,并探索性评价EDR综合护肤法的有效性和安全性。

要点

  • 本研究为单中心随机对照试验,计划纳入18-35岁毛周角化病患者72例。
  • 治疗组接受EDR综合护肤干预,对照组接受0.1%维A酸乳膏干预,治疗期4周。
  • 主要结局为毛囊丘疹改善指数和皮肤角化程度,次要结局包括皮肤含水量、经皮水分丢失、皮肤弹性等。

核心结论

  • 本研究将首次直接比较EDR综合护肤法与0.1%维A酸乳膏治疗毛周角化病的效果,研究结果将为毛周角化病的临床管理提供证据。

研究设计与样本

  • 本研究为单中心、随机、对照临床试验,目标人群为18-35岁毛周角化病病例,参与者(n=72)随机分配至治疗组和对照组。
  • 治疗组接受EDR综合护肤干预,对照组接受0.1%维A酸乳膏干预。
  • 试验包括4周治疗期,于治疗开始后第7、14、21、28天进行指标检测和数据收集。

关键数值与推荐

  • 主要结局指标包括毛囊丘疹改善指数和皮肤角化程度评估。
  • 次要结局指标包括皮肤含水量、经皮水分丢失试验、皮肤弹性等。
  • 以受试者的皮损情况、血压、心率、心律和呼吸频率作为安全性评价指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Keratosis pilaris (KP) is a chronic skin disease characterized by keratinized hair follicle papules, typically occurring on the arms, thighs, and buttocks. At present, the external treatment plan for KP is relatively singular. To optimize the existing clinical external drug treatment plan for KP, improve side effects, and enhance patients' quality of life, we propose the Exfoliate-Dissolve-Repair (EDR) comprehensive skin care method. Based on the EDR concept, we have designed a treatment plan that combines body scrub and moisturizing lotion. This research plan aims to evaluate the safety and efficacy of a novel skincare combination therapy for KP through a randomized controlled trial. METHODS: This study is a single center, randomized, controlled clinical trial targeting cases of KP aged 18-35 years. Participants (n = 72) were randomly assigned to a treatment group and a control group. The treatment group received EDR comprehensive skin care intervention, while the control group received 0.1% retinoic acid cream intervention. The trial includes a 4-week treatment period, with indicator testing and data collection conducted at 7, 14, 21, and 28 days after the start of treatment. The main outcome measures include the improvement index of follicular papules and evaluation of skin keratinization degree. Secondary outcome measures include skin moisture content, transdermal moisture loss test, skin elasticity, etc. Use the skin lesion condition, blood pressure, heart rate, heart rhythm, and respiratory rate of the subjects as safety evaluation indicators. Exploratory evaluation of the effectiveness and safety of the EDR comprehensive skin care method for KP. DISCUSSION: This study will be the RCT to directly compare the effects of EDR comprehensive skincare approach and 0.1% retinoic acid cream in KP. Findings from the study will provide evidence to inform the clinical management of KP. TRIAL REGISTRATION: This protocol has been registered prospectively in ISRCTN under the ISRCTN14455606 on April 6, 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Du YJ, Cheng L, Qi FW, et al. Efficacy and safety of the Exfoliate-Dissolve-Repair skin care approach in the treatment of keratosis pilaris: a randomized controlled clinical trial study protocol. Trials. 2026. PMID: 41736049. doi:10.1186/s13063-026-09423-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。